Cargando…

2508. Evaluation of Infectious Diseases Complications in US Veterans with Opioid Use Disorder, a Single Site Experience

BACKGROUND: Opioid use disorder (OUD) affects 2.7 million people in the United States and rates of OUD diagnosis are rising in US Veterans (USV). Injection drug use (IDU), including opioids, can lead to acquisition of bloodborne infections and severe injection related infections (SIRI). This study a...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivastava, Pronoma, Modi, Viraj, Lier, Audun J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679230/
http://dx.doi.org/10.1093/ofid/ofad500.2126
_version_ 1785150545851318272
author Srivastava, Pronoma
Modi, Viraj
Lier, Audun J
author_facet Srivastava, Pronoma
Modi, Viraj
Lier, Audun J
author_sort Srivastava, Pronoma
collection PubMed
description BACKGROUND: Opioid use disorder (OUD) affects 2.7 million people in the United States and rates of OUD diagnosis are rising in US Veterans (USV). Injection drug use (IDU), including opioids, can lead to acquisition of bloodborne infections and severe injection related infections (SIRI). This study aims to describe infectious diseases epidemiology, substance use characteristics, and health care utilization in persons who inject drugs (PWID) and non-PWID with OUD who presented to the Northport Veterans Affairs Medical Center (NVAMC). [Figure: see text] METHODS: Data was collected from a retrospective chart review of Veterans aged >18 years who had an ICD9 or ICD10 diagnosis of OUD and presented to the NVAMC between 2010-2020. Demographics, concomitant substance use and prior overdose histories, receipt of medications for opioid use disorder (MOUD), prior infection histories, hospitalizations, and emergency department (ED) visits were compared between PWID and non-PWID. Two-sample T-tests and Chi-square analyses were utilized. RESULTS: We identified 502 USV with a diagnosis of OUD. Mean age was 52.6 years, 469 (93.4%) were male, 396 (78.9%) were white, 172 (34.3%) were employed and 216 (43%) had health insurance. Post-traumatic stress disorder (n=275, 54.8%) was the most frequent psychiatric diagnosis and 216 (43%) USV had a history of IDU. PWID were more likely to have unstable housing (71.3% PWID vs 21.7% non-PWID, p< 0.001), be unemployed (60.2% PWID vs 43.7% non-PWID, p< 0.001), use cocaine (77.8% PWID vs 59.1% non PWID, p< 0.001), have a history of incarceration (49.1% PWID vs 38.5% non PWID, p=0.002), and have a prior overdose (53.7% PWID vs 27.3% non PWID, p< 0.001). Among PWID, 134 (62%) had hepatitis C virus and 30 (13.9%) had at least 1 SIRI, most frequently a skin and soft tissue infection (n=29, 13.4%). PWID were more likely to be hospitalized with an infection (26.4% PWID vs. 12.2% non PWID, p< 0.001) and had more inpatient admissions (5.5 PWID vs. 3.51 non PWID, p=0.003). ED visit frequency did not differ between groups. [Figure: see text] CONCLUSION: Veterans with OUD frequently present to the NVAMC with infections that require hospitalization. USV with OUD, especially PWID, would benefit from increased social support, as well as screening and treatment for OUD related infections. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10679230
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106792302023-11-27 2508. Evaluation of Infectious Diseases Complications in US Veterans with Opioid Use Disorder, a Single Site Experience Srivastava, Pronoma Modi, Viraj Lier, Audun J Open Forum Infect Dis Abstract BACKGROUND: Opioid use disorder (OUD) affects 2.7 million people in the United States and rates of OUD diagnosis are rising in US Veterans (USV). Injection drug use (IDU), including opioids, can lead to acquisition of bloodborne infections and severe injection related infections (SIRI). This study aims to describe infectious diseases epidemiology, substance use characteristics, and health care utilization in persons who inject drugs (PWID) and non-PWID with OUD who presented to the Northport Veterans Affairs Medical Center (NVAMC). [Figure: see text] METHODS: Data was collected from a retrospective chart review of Veterans aged >18 years who had an ICD9 or ICD10 diagnosis of OUD and presented to the NVAMC between 2010-2020. Demographics, concomitant substance use and prior overdose histories, receipt of medications for opioid use disorder (MOUD), prior infection histories, hospitalizations, and emergency department (ED) visits were compared between PWID and non-PWID. Two-sample T-tests and Chi-square analyses were utilized. RESULTS: We identified 502 USV with a diagnosis of OUD. Mean age was 52.6 years, 469 (93.4%) were male, 396 (78.9%) were white, 172 (34.3%) were employed and 216 (43%) had health insurance. Post-traumatic stress disorder (n=275, 54.8%) was the most frequent psychiatric diagnosis and 216 (43%) USV had a history of IDU. PWID were more likely to have unstable housing (71.3% PWID vs 21.7% non-PWID, p< 0.001), be unemployed (60.2% PWID vs 43.7% non-PWID, p< 0.001), use cocaine (77.8% PWID vs 59.1% non PWID, p< 0.001), have a history of incarceration (49.1% PWID vs 38.5% non PWID, p=0.002), and have a prior overdose (53.7% PWID vs 27.3% non PWID, p< 0.001). Among PWID, 134 (62%) had hepatitis C virus and 30 (13.9%) had at least 1 SIRI, most frequently a skin and soft tissue infection (n=29, 13.4%). PWID were more likely to be hospitalized with an infection (26.4% PWID vs. 12.2% non PWID, p< 0.001) and had more inpatient admissions (5.5 PWID vs. 3.51 non PWID, p=0.003). ED visit frequency did not differ between groups. [Figure: see text] CONCLUSION: Veterans with OUD frequently present to the NVAMC with infections that require hospitalization. USV with OUD, especially PWID, would benefit from increased social support, as well as screening and treatment for OUD related infections. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10679230/ http://dx.doi.org/10.1093/ofid/ofad500.2126 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Srivastava, Pronoma
Modi, Viraj
Lier, Audun J
2508. Evaluation of Infectious Diseases Complications in US Veterans with Opioid Use Disorder, a Single Site Experience
title 2508. Evaluation of Infectious Diseases Complications in US Veterans with Opioid Use Disorder, a Single Site Experience
title_full 2508. Evaluation of Infectious Diseases Complications in US Veterans with Opioid Use Disorder, a Single Site Experience
title_fullStr 2508. Evaluation of Infectious Diseases Complications in US Veterans with Opioid Use Disorder, a Single Site Experience
title_full_unstemmed 2508. Evaluation of Infectious Diseases Complications in US Veterans with Opioid Use Disorder, a Single Site Experience
title_short 2508. Evaluation of Infectious Diseases Complications in US Veterans with Opioid Use Disorder, a Single Site Experience
title_sort 2508. evaluation of infectious diseases complications in us veterans with opioid use disorder, a single site experience
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679230/
http://dx.doi.org/10.1093/ofid/ofad500.2126
work_keys_str_mv AT srivastavapronoma 2508evaluationofinfectiousdiseasescomplicationsinusveteranswithopioidusedisorderasinglesiteexperience
AT modiviraj 2508evaluationofinfectiousdiseasescomplicationsinusveteranswithopioidusedisorderasinglesiteexperience
AT lieraudunj 2508evaluationofinfectiousdiseasescomplicationsinusveteranswithopioidusedisorderasinglesiteexperience